{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:27:13Z","timestamp":1764995233734,"version":"3.46.0"},"reference-count":24,"publisher":"BMJ","issue":"7","funder":[{"name":"Taipei Institute of Pathology","award":["TIP-107-001"],"award-info":[{"award-number":["TIP-107-001"]}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-161"],"award-info":[{"award-number":["V108C-161"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2019,11,16]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Although Ki67 labelling index (LI) is a prognostic and predictive marker in breast cancer, its accuracy and reproducibility must be validated before its clinical application. We aimed to evaluate the agreement of Ki67 LI in clinical practice in Taiwan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a Ki67 immunohistochemistry (IHC) proficiency test. The participants performed the Ki67 IHC test and measured the Ki67 LI of 10 cases of breast cancer tissue on a microarray slide. The staining quality was centrally reviewed based on the Ki67 staining of the tonsil surface epithelium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ki67 staining and counting methods are diverse in Taiwan. The reproducibility of Ki67 LI was poor to good (intraclass correlation coefficient: 0.581, 95% CI 0.354 to 0.802). The reproducibility and agreement in the high staining quality group were significantly higher than those in the low staining quality group. The majority of the Ki67 LIs derived from the low staining quality group were underestimated. Different counting methods did not reveal significant differences when determining Ki67 LI with microarray sections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We suggest using the surface epithelium of the tonsil as external control and achieving optimal staining results that consist of a high positive parabasal layer, a low positive intermediate layer and a negative superficial layer. Good Ki67 staining quality can minimise the staining variations among different laboratories, and it is essential for the reproducibility of Ki67 LI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2019-206205","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T17:15:47Z","timestamp":1575393347000},"page":"413-417","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Good staining quality ensuring the reproducibility of Ki67 assessment"],"prefix":"10.1136","volume":"73","author":[{"given":"Yeh-Han","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Anatomic Pathology, Taipei Institute of Pathology, Taipei, Taiwan"},{"name":"Institute of Public Health, National Yang-Ming University, Taipei, Taiwan"},{"name":"College of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Ru","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang-Chun","family":"Lien","sequence":"additional","affiliation":[{"name":"Graduate Institute of Pathology, National Taiwan University, Taipei, Taiwan"},{"name":"Department of Pathology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-4291","authenticated-orcid":false,"given":"Chih-Yi","family":"Hsu","sequence":"additional","affiliation":[{"name":"College of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan"},{"name":"Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"2025120519331995000_73.7.413.1","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1200\/JCO.2017.74.0472","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of clinical oncology clinical practice guideline focused update","volume":"35","author":"Krop","year":"2017","journal-title":"JCO"},{"key":"2025120519331995000_73.7.413.2","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: breast cancer (version 3.2019), 2019. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf [Accessed Oct 27, 2019]."},{"key":"2025120519331995000_73.7.413.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp322"},{"key":"2025120519331995000_73.7.413.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr304"},{"key":"2025120519331995000_73.7.413.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt303"},{"key":"2025120519331995000_73.7.413.6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv221"},{"key":"2025120519331995000_73.7.413.7","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"2025120519331995000_73.7.413.8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr393"},{"key":"2025120519331995000_73.7.413.9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.38"},{"key":"2025120519331995000_73.7.413.10","doi-asserted-by":"crossref","unstructured":"Leung SCY , Nielsen TO , Zabaglo L , et al . Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration. npj Breast Cancer 2016;2.doi:10.1038\/npjbcancer.2016.14","DOI":"10.1038\/npjbcancer.2016.14"},{"key":"2025120519331995000_73.7.413.11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/his.12228","article-title":"Tonsil surface epithelium is ideal for monitoring Ki-67 immunohistochemical staining","volume":"63","author":"Hsu","year":"2013","journal-title":"Histopathology"},{"key":"2025120519331995000_73.7.413.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"2025120519331995000_73.7.413.13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2017.01.011","article-title":"Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter?","volume":"65","author":"\u00c1cs","year":"2017","journal-title":"Hum Pathol"},{"key":"2025120519331995000_73.7.413.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172031","article-title":"A comparison of Ki-67 counting methods in luminal breast cancer: the average method vs. the hot spot method","volume":"12","author":"Jang","year":"2017","journal-title":"PLoS One"},{"key":"2025120519331995000_73.7.413.15","doi-asserted-by":"publisher","DOI":"10.1002\/path.1218"},{"key":"2025120519331995000_73.7.413.16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2017.07.041","article-title":"Interlaboratory variability of Ki67 staining in breast cancer","volume":"84","author":"Focke","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025120519331995000_73.7.413.17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt306"},{"key":"2025120519331995000_73.7.413.18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2015.05.016","article-title":"The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer","volume":"46","author":"Christgen","year":"2015","journal-title":"Hum Pathol"},{"key":"2025120519331995000_73.7.413.19","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-9-118","article-title":"A novel model for Ki67 assessment in breast cancer","volume":"9","author":"Romero","year":"2014","journal-title":"Diagn Pathol"},{"key":"2025120519331995000_73.7.413.20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-016-3950-5","article-title":"St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods","volume":"159","author":"Focke","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2025120519331995000_73.7.413.21","doi-asserted-by":"crossref","unstructured":"Tuominen VJ , Ruotoistenm\u00e4ki S , Viitanen A , et al . ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010;12.doi:10.1186\/bcr2615","DOI":"10.1186\/bcr2615"},{"key":"2025120519331995000_73.7.413.22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-018-4669-2","article-title":"Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement","volume":"169","author":"Koopman","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2025120519331995000_73.7.413.23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41374-018-0123-7","article-title":"Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study","volume":"99","author":"Acs","year":"2019","journal-title":"Lab Invest"},{"key":"2025120519331995000_73.7.413.24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41379-018-0109-4","article-title":"An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer","volume":"32","author":"Rimm","year":"2019","journal-title":"Mod Pathol"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2019-206205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:33:32Z","timestamp":1764992012000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2019-206205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/jclinpath-2019-206205"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2019-206205","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}